Drug intelligence / Profile preview

Lifepearls-Irinotecan

Development stage
Unknown
Lead developer
Terumo
Modality
Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration
Intra-arterial
01

Overview

Lifepearls-Irinotecan is a chemoembolization system used for the treatment of liver tumors, particularly colorectal cancer liver metastases (CRCLM). It consists of Lifepearls, which are CE-marked, biocompatible, non-resorbable hydrogel microspheres, loaded with the chemotherapeutic agent irinotecan. The system is administered via transarterial chemoembolization (TACE), where the microspheres mechanically occlude the tumor's blood supply (embolization) while simultaneously providing a sustained, localized release of irinotecan directly into the tumor tissue. This targeted approach aims to maximize local drug concentration and tumor necrosis while minimizing systemic exposure and toxicity. Irinotecan, a topoisomerase I inhibitor, is converted into its active metabolite SN-38, which induces double-strand DNA breaks, leading to cell death in rapidly dividing cancer cells.

Brand names
Lifepearls
Other names
LIVERPEARLS-IrinotecanIrinotecan-loaded LifepearlsIrinotecan-eluting beadsDEBIRI
02

Targets

TOP1 (DNA Topoisomerase I)

Beyond the preview

Go deeper on Lifepearls-Irinotecan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lifepearls-Irinotecan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call